---
title: Activating Natural Killer Cell Receptors, Selectins, and Inhibitory Siglecs
  Recognize Ebolavirus Glycoprotein
type: pub
encoding: UTF-8

---
<h1>Publikasjon</h1>
<article id="csl-bib-container-EQT7XYW7" class="csl-bib-container">
  <div class="csl-bib-body"> <div class="csl-entry">Jarahian, M., Marstaller, K., Banna, N., Ahani, R., Etemadzadeh, M. H., Boller, L. K., Azadmanesh, K., Cid-Arregui, A., Khezri, A., Berger, M. R., Momburg, F., &#38; Watzl, C. (2021). Activating Natural Killer Cell Receptors, Selectins, and Inhibitory Siglecs Recognize Ebolavirus Glycoprotein. <i>Journal of Innate Immunity</i>. <a href="https://doi.org/10.1159/000517628">https://doi.org/10.1159/000517628</a></div> </div>
  <div class="csl-bib-buttons">
    <a href="#taxonomy-article-EQT7XYW7" alt="archive" class="csl-bib-button">Arkiv</a>
    <a href="https://app.cristin.no/results/show.jsf?id=1965731" alt="Cristin" class="csl-bib-button">Cristin</a>
    <a href="http://zotero.org/groups/5881554/items/EQT7XYW7" alt="Zotero" class="csl-bib-button">Zotero</a>
    <a href="#keywords-article-EQT7XYW7" alt="keywords" class="csl-bib-button">Emneord</a>
    <a href="#about-article-EQT7XYW7" alt="about_pub" class="csl-bib-button">Om</a>
    <a href="#sdg-article-EQT7XYW7" alt="sdg" class="csl-bib-button">Berekraftsmål</a>
  </div>
  <div id="csl-bib-meta-container-EQT7XYW7"></div>
</article>
<div id="csl-bib-meta-EQT7XYW7" class="csl-bib-meta">
  <article id="about-article-EQT7XYW7" class="about_pub-article">
    <h1>Om</h1>
    Jarahian et al. studerte korleis glycoproteinet til Ebolaviruset (EBOV-GP) interagerer med ulike reseptorar på menneskeceller. Dei fann at EBOV-GP kan binde seg til reseptorar på naturlege drepeceller (NK-celler), selektinar (molekyl som hjelper celler å feste seg saman), og inhiberande reseptorar som Siglecs. Desse interaksjonane kan både aktivere og undertrykke immunsystemet, noko som gjer det vanskelegare for NK-celler å øydeleggje infiserte celler. Denne doble effekten viser den komplekse kampen mellom immunsystemet og virus. Å forstå desse interaksjonane kan føre til nye måtar å behandle Ebola-infeksjonar på ved å målrette desse spesifikke reseptorane og forbetre immunresponsar. Denne forskinga er publisert i Journal of Innate Immunity.
  </article>
  <article id="keywords-article-EQT7XYW7" class="keywords-article">
    <h1>Emneord</h1>
    Ebolavirus Glycoprotein, Naturlege drepeceller, Selektinar, Siglecs, Immunsystem, Viral Patogenisitet
  </article>
  <article id="abstract-article-EQT7XYW7" class="abstract-article">
    <h1>Samandrag</h1>
    Expression of the extensively glycosylated Ebolavirus glycoprotein (EBOV-GP) induces physical alterations of surface molecules and plays a crucial role in viral pathogenicity. Here we investigate the interactions of EBOV-GP with host surface molecules using purified EBOV-GP, EBOV-GP-transfected cell lines, and EBOV-GP-pseudotyped lentiviral particles. Subsequently, we wanted to examine which receptors are involved in this recognition by binding studies to cells transfected with the EBOV-GP as well as to recombinant soluble EBOVGP. As the viral components can also bind to inhibitory receptors of immune cells (e.g., Siglecs, TIM-1), they can even suppress the activity of immune effector cells. Our data show that natural killer (NK) cell receptors NKp44 and NKp46, selectins (CD62E/P/L), the host factors DC-SIGNR/DC-SIGN, and inhibitory Siglecs function as receptors for EBOV-GP. Our results show also moderate to strong avidity of homing receptors (P-, L-, and E-selectin) and DC-SIGNR/DC-SIGN to purified EBOV-GP, to cells transfected with EBOV-GP, as well as to the envelope of a pseudotyped lentiviral vector carrying the EBOV-GP. The concomitant activation and inhibition of the immune system exemplifies the evolutionary antagonism between the immune system and pathogens. Altogether these interactions with activating and inhibitory receptors result in a reduced NK cell-mediated lysis of EBOVGP- expressing cells. Modulation of these interactions may provide new strategies for treating infections caused by this virus.
  </article>
  <article id="sdg-article-EQT7XYW7" class="sdg-article">
    <h1>Berekraftsmål</h1>
    <div class="sdg-container"><div id="sdg3" class="sdg">
        <img src="{{< params subfolder >}}images/sdg/sdg03_nn.png" class="image" alt="SDG 3">
        <div class="sdg-overlay">
          <a href="{{< params subfolder >}}nn/archive/?sdg=3#archive" class="sdg-publication-count"><span>1377</span> publikasjonar</a>
          <p><a href="https://fn.no/om-fn/fns-baerekraftsmaal/god-helse-og-livskvalitet?lang=nno-NO" class="sdg-read-more">Les meir</a></p>
        </div>
      </div></div>
  </article>
  <article id="taxonomy-article-EQT7XYW7" class="taxonomy-article">
    <h1>Arkiv</h1>
    <ul>
      <li><a href="{{< params subfolder >}}nn/archive/?key=3DCRN523">Universitetet i Innlandet</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=T77LXH6D">Fakultet for anvendt økologi, landbruksfag og bioteknologi</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=VL6KDQ85">Institutt for bioteknologi</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=FJH75VJD">2021</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=H75X8VE3">Desember</a></li>
    </ul>
  </article>
</div>
